Brian Abrahams
Stock Analyst at RBC Capital
(2.42)
# 2,444
Out of 5,109 analysts
450
Total ratings
47.13%
Success rate
-1.33%
Average return
Main Sectors:
Stocks Rated by Brian Abrahams
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| KYMR Kymera Therapeutics | Maintains: Outperform | $70 → $103 | $83.33 | +23.60% | 2 | Dec 16, 2025 | |
| NBIX Neurocrine Biosciences | Maintains: Outperform | $160 → $180 | $146.93 | +22.51% | 24 | Dec 8, 2025 | |
| SION Sionna Therapeutics | Downgrades: Underperform | $24 | $44.03 | -45.49% | 2 | Dec 1, 2025 | |
| PTCT PTC Therapeutics | Downgrades: Sector Perform | $82 → $91 | $78.37 | +16.12% | 23 | Dec 1, 2025 | |
| NMRA Neumora Therapeutics | Upgrades: Outperform | $4 → $7 | $1.81 | +286.74% | 7 | Dec 1, 2025 | |
| CTNM Contineum Therapeutics | Maintains: Outperform | $25 → $22 | $12.68 | +73.50% | 6 | Nov 21, 2025 | |
| AARD Aardvark Therapeutics | Maintains: Outperform | $19 → $18 | $14.26 | +26.23% | 5 | Nov 14, 2025 | |
| CRBP Corbus Pharmaceuticals Holdings | Maintains: Outperform | $55 → $53 | $8.43 | +528.71% | 9 | Nov 13, 2025 | |
| ATYR aTyr Pharma | Maintains: Sector Perform | $1.5 → $1 | $0.74 | +35.48% | 2 | Nov 7, 2025 | |
| PRTA Prothena Corporation | Maintains: Sector Perform | $10 → $11 | $9.69 | +13.52% | 12 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $3 → $2 | $1.23 | +62.60% | 14 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $21 → $20 | $13.43 | +48.92% | 10 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $28 → $32 | $32.99 | -3.00% | 13 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $137 → $145 | $220.86 | -34.35% | 2 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $34 → $32 | $27.87 | +14.82% | 3 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $55 → $58 | $45.01 | +28.86% | 20 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $423 → $415 | $462.99 | -10.37% | 56 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $30 → $19 | $7.47 | +154.35% | 13 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $60 → $70 | $78.03 | -10.29% | 2 | Nov 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $100 → $105 | $125.67 | -16.45% | 34 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $217 → $210 | $176.33 | +19.09% | 41 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $704 → $708 | $783.71 | -9.66% | 34 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $81 → $84 | $100.44 | -16.37% | 24 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Perform | $67 → $10 | $13.87 | -27.90% | 3 | Sep 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $25 → $23 | $22.32 | +3.05% | 35 | Jul 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $13 | $7.70 | +68.83% | 19 | Jun 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Sector Perform | $1.5 | $0.12 | +1,199.83% | 6 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $84 | $22.98 | +265.54% | 1 | Apr 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $31 | $12.75 | +143.23% | 1 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $139 → $143 | $153.64 | -6.93% | 2 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $40 | $35.65 | +12.20% | 1 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $25 → $15 | $16.60 | -9.64% | 14 | Oct 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $12 → $9 | $4.19 | +114.80% | 3 | Mar 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $21 → $33 | $96.91 | -65.95% | 3 | Nov 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $34.58 | - | 4 | Dec 4, 2017 |
Kymera Therapeutics
Dec 16, 2025
Maintains: Outperform
Price Target: $70 → $103
Current: $83.33
Upside: +23.60%
Neurocrine Biosciences
Dec 8, 2025
Maintains: Outperform
Price Target: $160 → $180
Current: $146.93
Upside: +22.51%
Sionna Therapeutics
Dec 1, 2025
Downgrades: Underperform
Price Target: $24
Current: $44.03
Upside: -45.49%
PTC Therapeutics
Dec 1, 2025
Downgrades: Sector Perform
Price Target: $82 → $91
Current: $78.37
Upside: +16.12%
Neumora Therapeutics
Dec 1, 2025
Upgrades: Outperform
Price Target: $4 → $7
Current: $1.81
Upside: +286.74%
Contineum Therapeutics
Nov 21, 2025
Maintains: Outperform
Price Target: $25 → $22
Current: $12.68
Upside: +73.50%
Aardvark Therapeutics
Nov 14, 2025
Maintains: Outperform
Price Target: $19 → $18
Current: $14.26
Upside: +26.23%
Corbus Pharmaceuticals Holdings
Nov 13, 2025
Maintains: Outperform
Price Target: $55 → $53
Current: $8.43
Upside: +528.71%
aTyr Pharma
Nov 7, 2025
Maintains: Sector Perform
Price Target: $1.5 → $1
Current: $0.74
Upside: +35.48%
Prothena Corporation
Nov 7, 2025
Maintains: Sector Perform
Price Target: $10 → $11
Current: $9.69
Upside: +13.52%
Nov 7, 2025
Maintains: Sector Perform
Price Target: $3 → $2
Current: $1.23
Upside: +62.60%
Nov 7, 2025
Maintains: Outperform
Price Target: $21 → $20
Current: $13.43
Upside: +48.92%
Nov 7, 2025
Maintains: Sector Perform
Price Target: $28 → $32
Current: $32.99
Upside: -3.00%
Nov 7, 2025
Maintains: Outperform
Price Target: $137 → $145
Current: $220.86
Upside: -34.35%
Nov 6, 2025
Maintains: Outperform
Price Target: $34 → $32
Current: $27.87
Upside: +14.82%
Nov 4, 2025
Maintains: Outperform
Price Target: $55 → $58
Current: $45.01
Upside: +28.86%
Nov 4, 2025
Maintains: Sector Perform
Price Target: $423 → $415
Current: $462.99
Upside: -10.37%
Nov 4, 2025
Maintains: Outperform
Price Target: $30 → $19
Current: $7.47
Upside: +154.35%
Nov 3, 2025
Maintains: Outperform
Price Target: $60 → $70
Current: $78.03
Upside: -10.29%
Oct 31, 2025
Maintains: Sector Perform
Price Target: $100 → $105
Current: $125.67
Upside: -16.45%
Oct 31, 2025
Maintains: Outperform
Price Target: $217 → $210
Current: $176.33
Upside: +19.09%
Oct 29, 2025
Maintains: Sector Perform
Price Target: $704 → $708
Current: $783.71
Upside: -9.66%
Oct 29, 2025
Maintains: Sector Perform
Price Target: $81 → $84
Current: $100.44
Upside: -16.37%
Sep 29, 2025
Downgrades: Sector Perform
Price Target: $67 → $10
Current: $13.87
Upside: -27.90%
Jul 17, 2025
Maintains: Sector Perform
Price Target: $25 → $23
Current: $22.32
Upside: +3.05%
Jun 30, 2025
Reiterates: Outperform
Price Target: $13
Current: $7.70
Upside: +68.83%
May 14, 2025
Reiterates: Sector Perform
Price Target: $1.5
Current: $0.12
Upside: +1,199.83%
Apr 22, 2025
Reiterates: Outperform
Price Target: $84
Current: $22.98
Upside: +265.54%
Mar 7, 2025
Initiates: Outperform
Price Target: $31
Current: $12.75
Upside: +143.23%
Feb 3, 2025
Maintains: Outperform
Price Target: $139 → $143
Current: $153.64
Upside: -6.93%
Jan 28, 2025
Reiterates: Outperform
Price Target: $40
Current: $35.65
Upside: +12.20%
Oct 2, 2023
Maintains: Sector Perform
Price Target: $25 → $15
Current: $16.60
Upside: -9.64%
Mar 31, 2022
Maintains: Sector Perform
Price Target: $12 → $9
Current: $4.19
Upside: +114.80%
Nov 3, 2021
Maintains: Sector Perform
Price Target: $21 → $33
Current: $96.91
Upside: -65.95%
Dec 4, 2017
Upgrades: Buy
Price Target: n/a
Current: $34.58
Upside: -